201064 Creating an evidence-based hepatitis C risk assessment card: The Harlem Hepatitis C Task Force

Monday, November 9, 2009: 1:35 PM

Donald Gardenier, DNP , Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY
Nirah Johnson, LMSW , Office of Viral Hepatitis Coordination, New York City Department of Health and Mental Hygiene, New York, NY
Natalie Kil, MPH , Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY
Thomas G. McGinn, MD MPH , Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY
Disparate rates of hepatitis C (HCV) prevalence have been reported in particular populations, geographic areas and settings. HCV prevalence rates in Harlem are estimated to be among the highest in New York City (NYC) and are thought to occur as a result of higher incidence of HCV risk factors. The Centers for Disease Control recommends that adults in the United States be assessed for HCV risk factors, and that those at risk be tested for HCV antibodies in the blood. In 2002, Mount Sinai School of Medicine (MSSM), a Harlem-based health care provider, conducted a study that screened 1000 randomly selected adults on 27 HCV Risk Factors; provided HCV antibody testing for all; and preformed multivariable logistic regression analysis to identify risk factors associated with HCV antibodies. The study results were published in 2008 and the first validated HCV Risk Assessment Screening Tool was created. When the National Institutes of Health called for increased outreach to individuals in need of HCV evaluation and treatment in 2002, Harlem health care providers were not yet networked to respond effectively. In 2008, MSSM and the NYC Department of Health and Mental Hygiene partnered with key community-based organizations to form the Harlem HCV Task Force, the fourth in a network of NYC coalitions that collectively identify and meet critical needs HCV-affected communities. The first Harlem Task Force project was to transform MSSM's validated HCV risk assessment tool into an HCV Risk Assessment Card that will be distributed throughout NYC by the task force network.

Learning Objectives:
Describe the process by which evidence generated in a community-based research study can be tanslated into a risk assessment instrument to be used in the community.

Keywords: Community-Based Partnership, Hepatitis C

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I hold a Master's Degree in Public Health and am the project manager of the team that designed this research and its community health application.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

See more of: Infectious Disease Epidemiology
See more of: Epidemiology